Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

NCT00283062 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Docetaxel (TAXOTERE®) Chemotherapy
DRUG: Leuprolide acetate ( ELIGARD®) Hormonal Therapy
DRUG: Docetaxel (TAXOTERE®) Chemotherapy
DRUG: Leuprolide acetate ( ELIGARD®) Hormonal Therapy
DRUG: Leuprolide acetate ( ELIGARD®) Hormonal Therapy

Sponsor

Sanofi